Marwa Asar, M. Mansour, Nader Eleneen, Rania Bahriz
{"title":"疼痛性糖尿病周围神经病变的主观与客观评价","authors":"Marwa Asar, M. Mansour, Nader Eleneen, Rania Bahriz","doi":"10.4103/ejode.ejode_5_21","DOIUrl":null,"url":null,"abstract":"Introduction Diabetic peripheral neuropathy (DPN) is one of the commonest chronic complications of diabetes mellitus. It is documented that 26.4% of the cases with type 2 diabetes mellitus have painful DPN, whereas approximately half of the DPN cases may not have symptoms. Although neurophysiologic studies represent an objective and sensitive tool in the diagnosis of diabetic neuropathy, they remain limited owing to many factors; thus, there is a need to develop simpler tools that can fit into this gap, hence the development of different neuropathy scores. Aim To evaluate different tools and methods either subjective or objective in diagnosis of painful DPN in type 2 diabetic patients. Patients and methods We included 200 cases with type 2 diabetes mellitus recruited from the diabetes and diabetic neuropathy clinics in Mansoura Specialized Medical Hospital fulfilling the inclusion and exclusion criteria. They were divided into two groups: group 1 included 150 diabetic cases with painful peripheral diabetic neuropathy, and group 2 included 50 diabetic cases without neuropathy. Results Glycated hemoglobin was significantly elevated in the peripheral neuropathy group compared with the other group (8.24 vs. 7.27%; P<0.001). Regarding neutrophil/lymphocytic ratio in our study, it was not significantly different between the two groups (P=0581). It had mean values of 2.17 and 2.1 in groups 1 and 2, respectively. Conclusion Higher grades of the scores performed in this study were associated with a severe form of neuropathy. Both duration of diabetes and glycated hemoglobin levels had a significant positive correlation with these scores. Regarding neutrophil/lymphocytic ratio in our study, it did not show a significant difference between the two groups.","PeriodicalId":260758,"journal":{"name":"Egyptian Journal of Obesity, Diabetes and Endocrinology","volume":"55 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Subjective versus objective assessment of painful diabetic peripheral neuropathy\",\"authors\":\"Marwa Asar, M. Mansour, Nader Eleneen, Rania Bahriz\",\"doi\":\"10.4103/ejode.ejode_5_21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction Diabetic peripheral neuropathy (DPN) is one of the commonest chronic complications of diabetes mellitus. It is documented that 26.4% of the cases with type 2 diabetes mellitus have painful DPN, whereas approximately half of the DPN cases may not have symptoms. Although neurophysiologic studies represent an objective and sensitive tool in the diagnosis of diabetic neuropathy, they remain limited owing to many factors; thus, there is a need to develop simpler tools that can fit into this gap, hence the development of different neuropathy scores. Aim To evaluate different tools and methods either subjective or objective in diagnosis of painful DPN in type 2 diabetic patients. Patients and methods We included 200 cases with type 2 diabetes mellitus recruited from the diabetes and diabetic neuropathy clinics in Mansoura Specialized Medical Hospital fulfilling the inclusion and exclusion criteria. They were divided into two groups: group 1 included 150 diabetic cases with painful peripheral diabetic neuropathy, and group 2 included 50 diabetic cases without neuropathy. Results Glycated hemoglobin was significantly elevated in the peripheral neuropathy group compared with the other group (8.24 vs. 7.27%; P<0.001). Regarding neutrophil/lymphocytic ratio in our study, it was not significantly different between the two groups (P=0581). It had mean values of 2.17 and 2.1 in groups 1 and 2, respectively. Conclusion Higher grades of the scores performed in this study were associated with a severe form of neuropathy. Both duration of diabetes and glycated hemoglobin levels had a significant positive correlation with these scores. Regarding neutrophil/lymphocytic ratio in our study, it did not show a significant difference between the two groups.\",\"PeriodicalId\":260758,\"journal\":{\"name\":\"Egyptian Journal of Obesity, Diabetes and Endocrinology\",\"volume\":\"55 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Egyptian Journal of Obesity, Diabetes and Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ejode.ejode_5_21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Obesity, Diabetes and Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ejode.ejode_5_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
糖尿病周围神经病变是糖尿病最常见的慢性并发症之一。据文献记载,26.4%的2型糖尿病患者有疼痛的DPN,而大约一半的DPN病例可能没有症状。虽然神经生理学研究是诊断糖尿病神经病变的客观和敏感的工具,但由于许多因素,它们仍然受到限制;因此,有必要开发更简单的工具来填补这一空白,从而开发出不同的神经病变评分。目的探讨主客观诊断2型糖尿病患者疼痛性DPN的不同工具和方法。患者和方法我们从曼苏拉专科医院糖尿病和糖尿病神经病变门诊招募200例符合纳入和排除标准的2型糖尿病患者。将患者分为两组:1组150例伴有疼痛性糖尿病周围神经病变,2组50例无神经病变。结果周围神经病变组糖化血红蛋白明显升高(8.24% vs. 7.27%;P < 0.001)。在我们的研究中,中性粒细胞/淋巴细胞比率在两组之间无显著差异(P=0581)。1组和2组的平均值分别为2.17和2.1。结论:在这项研究中,较高的评分与严重的神经病变有关。糖尿病持续时间和糖化血红蛋白水平与这些评分均有显著正相关。在我们的研究中,中性粒细胞/淋巴细胞比率在两组之间没有明显差异。
Subjective versus objective assessment of painful diabetic peripheral neuropathy
Introduction Diabetic peripheral neuropathy (DPN) is one of the commonest chronic complications of diabetes mellitus. It is documented that 26.4% of the cases with type 2 diabetes mellitus have painful DPN, whereas approximately half of the DPN cases may not have symptoms. Although neurophysiologic studies represent an objective and sensitive tool in the diagnosis of diabetic neuropathy, they remain limited owing to many factors; thus, there is a need to develop simpler tools that can fit into this gap, hence the development of different neuropathy scores. Aim To evaluate different tools and methods either subjective or objective in diagnosis of painful DPN in type 2 diabetic patients. Patients and methods We included 200 cases with type 2 diabetes mellitus recruited from the diabetes and diabetic neuropathy clinics in Mansoura Specialized Medical Hospital fulfilling the inclusion and exclusion criteria. They were divided into two groups: group 1 included 150 diabetic cases with painful peripheral diabetic neuropathy, and group 2 included 50 diabetic cases without neuropathy. Results Glycated hemoglobin was significantly elevated in the peripheral neuropathy group compared with the other group (8.24 vs. 7.27%; P<0.001). Regarding neutrophil/lymphocytic ratio in our study, it was not significantly different between the two groups (P=0581). It had mean values of 2.17 and 2.1 in groups 1 and 2, respectively. Conclusion Higher grades of the scores performed in this study were associated with a severe form of neuropathy. Both duration of diabetes and glycated hemoglobin levels had a significant positive correlation with these scores. Regarding neutrophil/lymphocytic ratio in our study, it did not show a significant difference between the two groups.